NutriBand (NTRB) Goodwill & Intangibles (2017 - 2026)
NutriBand (NTRB) posted Goodwill & Intangibles of $2.6 million for Q2 2026, little changed sequentially from $2.6 million in Q1 2026, and up 30.15% YoY from $2.0 million in Q2 2025.
NutriBand (NTRB) Goodwill & Intangibles (2017 - 2026) Analysis & Trends
NutriBand has reported Goodwill & Intangibles for 10 years, with the latest figure at $2.6 million in Q2 2026.
- Quarterly Goodwill & Intangibles rose 30.15% year-over-year to $2.6 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $2.6 million (up 30.15% YoY) and the FY2026 annual result came in at $2.6 million, up 29.15% from the prior year.
- Goodwill & Intangibles steadied at $2.6 million in Q2 2026 per NTRB's latest filing, from $2.6 million in the prior quarter.
- Over five years, Goodwill & Intangibles peaked at $6.3 million in Q1 2022 and troughed at $2.0 million in Q3 2025.
- A 5-year average of $4.7 million and a median of $5.7 million in 2023 frame the typical range for Goodwill & Intangibles.
- The sharpest annual moves came in 2025 and 2026: Goodwill & Intangibles sank 68.3% in 2025, then surged 30.15% in 2026.
- Over 5 years, Goodwill & Intangibles stood at $6.2 million in 2022, then fell by 7.15% to $5.7 million in 2023, then rose by 7.62% to $6.2 million in 2024, then slumped by 58.43% to $2.6 million in 2025, then changed by 0.0% to $2.6 million in 2026.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered $2.6 million, $2.6 million, and $2.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | NutriBand | 57.74 Mn | 53.73 Mn | 196,801.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 2.56 Mn |
| Jan 31, 2026 | 2.56 Mn |
| Oct 31, 2025 | 2.56 Mn |
| Jul 31, 2025 | 1.95 Mn |
| Apr 30, 2025 | 1.97 Mn |
| Jan 31, 2025 | 1.98 Mn |
| Oct 31, 2024 | 6.15 Mn |
| Jul 31, 2024 | 6.15 Mn |
| Apr 30, 2024 | 5.66 Mn |
| Jan 31, 2024 | 5.69 Mn |
| Oct 31, 2023 | 5.72 Mn |
| Jul 31, 2023 | 5.75 Mn |
| Apr 30, 2023 | 5.77 Mn |
| Jan 31, 2023 | 5.80 Mn |
| Oct 31, 2022 | 6.16 Mn |
| Jul 31, 2022 | 6.21 Mn |
| Apr 30, 2022 | 6.24 Mn |
| Jan 31, 2022 | 6.28 Mn |
| Oct 31, 2021 | 8.49 Mn |
| Jul 31, 2021 | 6.80 Mn |